14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MEDS
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Trxade Group Inc. stock downgraded after the last trading session.
(Updated on Jun 25, 2024)

Buy or Hold candidate since Jun 11, 2024 Gain 30.31% PDF

The Trxade Group Inc. stock price gained 4.16% on the last trading day (Tuesday, 25th Jun 2024), rising from $8.42 to $8.77. During the last trading day the stock fluctuated 8.09% from a day low at $8.41 to a day high of $9.09. The price has been going up and down for this period, and there has been a 47.52% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 thousand more shares were traded than the day before. In total, 31 thousand shares were bought and sold for approximately $270.50 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $9.55 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -14.52% during the next 3 months and, with a 90% probability hold a price between $4.22 and $8.16 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MEDS Signals & Forecast

The Trxade Group Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $8.71 and $6.68. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Trxade Group Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 18, 2024, and so far it has fallen -9.12%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Trxade Group Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $7.31 and $7.08. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Trxade Group Inc. finds support just below today's level at $7.31. If this is broken, then the next support from accumulated volume will be at $7.08 and $6.93.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.680 between high and low, or 8.09%. For the last week, the stock has had daily average volatility of 15.66%.

Our recommended stop-loss: $8.35 (-4.81%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 26 days ago.)

Trading Expectations (MEDS) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect Trxade Group Inc. to open at $8.76, and during the day (based on 14 day Average True Range), to move between $7.83 and $9.71, which gives a possible trading interval of +/-$0.94 (+/-10.66%) up or down from last closing price. If Trxade Group Inc. takes out the full calculated possible swing range there will be an estimated 21.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.24 (5.36%) than the support at $7.31 (16.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Trxade Group Inc. stock A Buy?

Trxade Group Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.792 Hold/Accumulate Downgraded

Predicted Opening Price for Trxade Group Inc. of Wednesday, June 26, 2024

Fair opening price June 26, 2024 Current price
$8.76 ( 0.152%) $8.77

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MEDS

Fibonacci Support & Resistance Levels

Level Price
R3 9.44 7.60%
R2 9.18 4.64%
R1 9.02 2.81%
Price 8.77
S1 8.50 -3.11%
S2 8.34 -4.94%
S3 8.08 -7.91%

Accumulated Volume Support & Resistance Levels

Level Price
R3 9.65 10.03%
R2 9.28 5.82%
R1 9.24 5.36%
Price 8.77
S1 7.31 -16.65%
S2 7.08 -19.27%
S3 6.93 -20.98%

MEDS Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 28, 2024 Mar 25, 2024 Mar 22, 2024 $8.00 33.24%
2 Mar 15, 2024 Mar 15, 2024 Mar 15, 2024 $0 0%

FAQ

What is the symbol for Trxade Group Inc. Stock and on which exchange is it traded?
The symbol for Trxade Group Inc. is MEDS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Trxade Group Inc. Stock?
Trxade Group Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Trxade Group Inc. Stock?
Trxade Group Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Trxade Group Inc. Stock.

What's the current price of Trxade Group Inc. Stock?
As of the end of day on the Jun 25, 2024, the price of an Trxade Group Inc. (MEDS) share was $8.77.

What is the 52-week high and low for Trxade Group Inc. Stock?
The 52-week high for Trxade Group Inc. Stock is $44.56 and the 52-week low is $3.81.

What is the market capitalization of Trxade Group Inc. Stock?
As of the Jun 25, 2024, the market capitalization of Trxade Group Inc. is 11.841M.

When is the next earnings date for Trxade Group Inc.?
The upcoming earnings date for Trxade Group Inc. is Aug 16, 2024.
Click to get the best stock tips daily for free!

About Trxade Group Inc.

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company w... MEDS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT